Literature DB >> 3156480

Coronary angioplasty: clinical and angiographic follow-up.

S Levine, C J Ewels, D R Rosing, K M Kent.   

Abstract

To evaluate the clinical status and restenosis rate after percutaneous transluminal coronary angiography (PTCA), 251 consecutive patients who had undergone a successful procedure from February 1979 to May 1983 were studied. Angiography was done routinely in 92 of the initial 100 consecutive patients in whom the procedure was successful (group I), 1 to 11 months (mean 6) after PTCA. Restenosis occurred in 37 of 92 patients (40%); all but 2 (who had collateral flow to the restenosed vessel) had symptoms. Conversely, 44 of 46 asymptomatic patients had no restenosis. The other 159 patients (group II) were followed up clinically, with angiography performed only if signs or symptoms of ischemia recurred. Restenosis suspected clinically and confirmed angiographically occurred in 35 of 92 patients (38%) in group I and 36 of 154 patients (23%) in group II. Of 251 patients with follow-up of at least 6 months, 109 patients (43%) became symptomatic. Of 109 symptomatic patients, 104 consented to coronary angiography; restenosis was found in 67%, progression of narrowing in other arteries occurred in 13%, and the remaining patients were presumed to have large or small vessel vasospasm. The mortality rate for the entire group was 0.8%. When repeat angioplasty was applied to patients with restenosis, over 80% of the group improved at an average follow-up time of 21 months. Symptomatic restenosis may occur less often when higher balloon inflation pressures are used during PTCA.

Entities:  

Mesh:

Year:  1985        PMID: 3156480     DOI: 10.1016/0002-9149(85)90134-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Restenosis following coronary angioplasty.

Authors:  K J Beatt; P W Serruys
Journal:  Int J Card Imaging       Date:  1990

2.  Application of intraluminal ultrasound imaging to vascular stenting.

Authors:  M J Slepian
Journal:  Int J Card Imaging       Date:  1991

Review 3.  Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

Authors:  J P Herrman; W R Hermans; J Vos; P W Serruys
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

4.  Pravastatin reduces restenosis after coronary angioplasty of high grade stenotic lesions: results of SHIPS (SHIga Pravastatin Study).

Authors:  Y Nakamura; O Yamaoka; K Uchida; N Morigami; Y Sugimoto; T Fujita; T Inoue; T Fuchi; M Hachisuka; H Ueshima; H Shimakawa; M Kinoshita
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

Review 5.  Percutaneous transluminal coronary angioplasty: state of the art and future directions.

Authors:  G S Roubin; A R Gruentzig
Journal:  Int J Card Imaging       Date:  1985

6.  Laser thermal angioplasty: from the experimental model to early human experience.

Authors:  T J Ryan; T A Sanborn; D C Cumberland; D P Faxon; C C Haudenschild
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

7.  Transluminal angioplasty of a stenosis of an internal mammary artery graft.

Authors:  P A Crean; P W Mathieson; A F Rickards
Journal:  Br Heart J       Date:  1986-11

8.  Percutaneous coronary angioplasty: technique, indications, and results.

Authors:  G S Roubin; A R Gruentzig; W J Casarella
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

Review 9.  Indications for routine heart-catheterization after CABG and PTCA.

Authors:  A Breeman; P W Serruys
Journal:  Int J Card Imaging       Date:  1993

10.  Value of a radionuclide limb blood flow technique in the assessment of percutaneous balloon and dynamic angioplasty.

Authors:  A A Gehani; P Thorley; K Sheard; S Ashley; S G Brook; M R Rees
Journal:  Eur J Nucl Med       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.